Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 19

CN20 - Nutriscore as a tool for selecting patients with low risk of nutritional complication safely

Date

10 Sep 2022

Session

Poster session 19

Topics

Nutritional Support

Tumour Site

Colon and Rectal Cancer

Presenters

Lidia Raventos

Citation

Annals of Oncology (2022) 33 (suppl_7): S812-S814. 10.1016/annonc/annonc1042

Authors

L. Raventos1, R.M. Legido-Diaz1, L. Arribas2, M. Bellver2, A.R. Gonzalez2, I. Peiró Martínez2

Author affiliations

  • 1 Functional Colorectal Cancer Unit, Institut Català d’Oncologia (ICO-L’Hospitalet), 08907 - Hospitalet de Llobregat/ES
  • 2 Functional Clinical Nutrition Unit, Institut Català d’Oncologia (ICO-L’Hospitalet), 08907 - Hospitalet de Llobregat/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN20

Background

NUTRISCORE is a validated nutritional screening tool for oncology outpatients setting, that stands out for its sensitivity, specificity, and simplicity. Our goal was to identify those patients with NUTRISCORE < 5 (without risk of malnutrition) who were not referred to the clinical nutrition unit (CNU) and to check whether they completed specific cancer treatment without nutritional complications or had to be referred to the CNU for nutritional assessment.

Methods

All patients (pts) attending the first oncology nursing visit of the colorectal cancer functional unit between April and November 2021 were prospectively included. The NUTRISCORE was computed at the initial assessment. The medical records of patients with score < 5 who were not referred to the CNU were selected to analyse whether they had developed nutritional complications after completing specific cancer treatment and required referral to the CNU.

Results

From the 92 pts included prospectively 19 pts (20.65%) were referred to the CNU at the first nursing visit and 70 pts were not referred (76.08%) as NUTRISCORE scores < 5. The mean age of the non-referred patients was 68.86 years. Of the 70 pts that weren’t referred, 22 were finally referred (31.42%) at some point during the cancer treatment. The reasons for referral were: 63.63% by protocol during colorectal surgery admission; 9.09% for being within a clinical trial that required nutritional assessment; 4.54% were being followed by CNU previously. Only the remaining 22.74% were referred due to nutritional complications: 18.18% pts related to tumour symptomatology (peritonitis, subocclusion...) and 4.54% for complications arise during the waiting time between the end of neoadjuvant and surgery. There were 3 pts with severe malnutrition, 10 pts with mild to moderate malnutrition, and 9 pts were well nourished. Oral nutritional support as required in 12 pts; 5 pts were received an adapted diet and 1 pts required treatment with folic acid + vitamin B12.

Conclusions

NUTRISCORE is a nutritional screening tool that need to be used also during the follow up visits to detect nutritional complications associated to treatment toxicity.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

L. Raventos, R. Legido-Diaz, L. Arribas.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.